High number of early respiratory infections in association with allergic sensitization to mold promotes childhood asthma - 04/05/18
Doi : 10.1016/j.jaci.2017.11.058
Leilanie Perez Ramirez, MD, MS a, Heepke Wendroth, MD b, Lisa J. Martin, PhD c, Valentina V. Pilipenko, PhD c, Hua He, MS c, John Kroner, MS b, Patrick H. Ryan, PhD d, Grace K. LeMasters, PhD e, James E. Lockey, MD, MS e, David I. Bernstein, MD, MS e, f, Gurjit K. Khurana Hershey, MD, PhD a, b, Jocelyn M. Biagini Myers, PhD b 
a Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
b Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
c Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
d Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
e Department of Environmental Health, University of Cincinnati, Cincinnati, Ohio
f Department of Immunology, Allergy and Rheumatology, University of Cincinnati, Cincinnati, Ohio
| Funding provided by the National Institutes of Health (NIH) grants 2T32AI060515-11 (L.P.R.), U19AI070235 (G.K.K.H., J.B.M.), and National Institute of Environmental Health Sciences grants RO1ES11170 and RO1ES019890 (P.H.R.). |
|
| Disclosure of potential conflict of interest: L. Perez Ramirez has received a grant from NIH (T32 grant). H. Wendroth has received grants from NIH (2T32AI060515-11) and the National Institute of Environmental Health Sciences (RO1ES019890, RO1ES11170). L. Martin, H. He, and G. Khurana Hershey have received grants from NIH. P. Ryan has received a grant from the National Institute of Environmental Health Sciences. D. Bernstein has received a grant from the University of Cincinnati; has a board membership with the American Board of Allergy; has consultant arrangements with Merck, GlaxoSmithKline, and Sanofi; and has received payment for lectures from Prime. J. Myers has received grants and travel support from NIH. The rest of the authors declare no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 141 - N° 5
P. 1921 - mai 2018 Retour au numéro
Article précédent
- Increased GATA-3 and T-bet expression in eosinophilic esophagitis versus gastroesophageal reflux disease
- Benjamin L. Wright, Nathalie Nguyen, Kelly P. Shim, Joanne C. Masterson, Elizabeth A. Jacobsen, Sergei I. Ochkur, James J. Lee, Glenn T. Furuta
- New human combined immunodeficiency caused by interferon regulatory factor 4 (IRF4) deficiency inherited by uniparental isodisomy
- María Bravo García-Morato, Francisco Javier Aracil Santos, Alejandro Contreras Briones, Alfonso Blázquez Moreno, Ángela del Pozo Maté, Ángeles Domínguez-Soto, María José Beato Merino, Lucía del Pino Molina, Juan Torres Canizales, Ana Victoria Marin, Elena Vallespín García, Marta Feito Rodríguez, Diego Plaza López Sabando, Anaïs Jiménez-Reinoso, Yasmina Mozo del Castillo, Francisco José Sanz Santaeufemia, Raúl de Lucas-Laguna, Paula P. Cárdenas, Laura Casamayor Polo, María Coronel Díaz, Mar Valés-Gómez, Ernesto Roldán Santiago, Antonio Ferreira Cerdán, Julián Nevado Blanco, Ángel L. Corbí, Hugh T. Reyburn, José Ramón Regueiro, Eduardo López-Granados, Rebeca Rodríguez Pena
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?